Triple-negative breast cancer (TNBC), defined as a tumor that lacks expression of the oestrogen receptor (ER), the progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounts for 15–20% of all breast cancer cases [1]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.